Interleukin-2_NN
promoter_NN
activity_NN
in_IN
Epstein-Barr_JJ
virus-transformed_JJ
B_NN
lymphocytes_NNS
is_VBZ
controlled_VBN
by_IN
nuclear_JJ
factor-chi_NN
B_NN
._.

The_DT
regulation_NN
of_IN
interleukin_NN
-LRB-_-LRB-
IL_NN
-RRB-_-RRB-
-2_CD
gene_NN
expression_NN
has_VBZ
been_VBN
investigated_VBN
mainly_RB
in_IN
T_NN
lymphocytes_NNS
,_,
the_DT
predominant_JJ
producers_NNS
of_IN
IL-2_NN
._.

However_RB
,_,
B_NN
cells_NNS
can_MD
also_RB
synthesize_VB
IL-2_NN
._.

In_IN
the_DT
present_JJ
study_NN
we_PRP
analyzed_VBD
the_DT
control_NN
of_IN
IL-2_NN
promoter_NN
activity_NN
in_IN
Epstein-Barr_JJ
virus_NN
-LRB-_-LRB-
EBV_NN
-RRB-_-RRB-
-_:
transformed_VBN
B_NN
cell_NN
clones_NNS
which_WDT
are_VBP
capable_JJ
of_IN
secreting_VBG
IL-2_NN
at_IN
a_DT
low_JJ
level_NN
after_IN
stimulation_NN
with_IN
phorbol_NN
12-myristate_NN
13-acetate_NN
and_CC
the_DT
Ca2_NN
+_CC
ionophore_NN
ionomycin_NN
._.

Transient_JJ
transfections_NNS
using_VBG
reporter_NN
constructs_NNS
with_IN
multiples_NNS
of_IN
transcription_NN
factor_NN
binding_NN
sites_NNS
from_IN
the_DT
IL-2_NN
promoter_NN
-LCB-_-LRB-
distal_JJ
nuclear_JJ
factor_NN
-LRB-_-LRB-
NF_NN
-RRB-_-RRB-
-_:
AT_NN
,_,
proximal_JJ
NF-AT_NN
,_,
AP-1_NN
\/_:
Octamer_NN
-LRB-_-LRB-
UPS_NN
-RRB-_-RRB-
or_CC
NF-chi_NN
B_NN
-LRB-_-LRB-
TCEd_NN
-RRB-_-RRB-
sites_NNS
-RCB-_-RRB-
were_VBD
performed_VBN
._.

In_IN
EBV-transformed_JJ
B_NN
clones_NNS
,_,
the_DT
chi_NN
B_NN
site_NN
exerted_VBD
the_DT
strongest_JJS
inducible_JJ
activity_NN
;_:
the_DT
NF-AT_NN
binding_NN
sites_NNS
showed_VBD
either_CC
no_DT
or_CC
only_RB
weak_JJ
activity_NN
compared_VBN
to_TO
Jurkat_NN
T_NN
cells_NNS
._.

An_DT
IL-2_NN
promoter_NN
bearing_VBG
a_DT
defective_JJ
NF-chi_NN
B_NN
site_NN
was_VBD
completely_RB
inactive_JJ
in_IN
EBV-transformed_JJ
B_NN
cells_NNS
,_,
while_IN
it_PRP
still_RB
had_VBD
activity_NN
in_IN
Jurkat_NN
T_NN
cells_NNS
._.

In_IN
seven_CD
EBV-B_NN
cell_NN
clones_NNS
or_CC
lines_NNS
differing_VBG
in_IN
their_PRP$
capacity_NN
to_TO
secrete_VB
IL-2_NN
,_,
the_DT
activity_NN
of_IN
the_DT
IL-2_NN
promoter_NN
correlated_VBD
well_RB
with_IN
the_DT
status_NN
of_IN
IL-2_NN
secretion_NN
._.

Similarly_RB
,_,
a_DT
human_JJ
immunodeficiency_NN
virus_NN
promoter_NN
,_,
whose_WP$
activity_NN
is_VBZ
controlled_VBN
through_IN
chi_NN
B_NN
factors_NNS
,_,
was_VBD
found_VBN
to_TO
be_VB
active_JJ
in_IN
the_DT
IL-2_NN
producing_VBG
EBV-B_NN
cells_NNS
,_,
but_CC
inactive_JJ
in_IN
the_DT
non-IL-2-producing_JJ
cells_NNS
._.

Electrophoretic_JJ
mobility_NN
shift_NN
assays_NNS
using_VBG
protein_NN
extracts_NNS
from_IN
EBV-B_NN
cells_NNS
and_CC
the_DT
IL-2_NN
NF-chi_NN
B_NN
probe_NN
revealed_VBD
the_DT
constitutive_JJ
generation_NN
of_IN
chi_NN
B_NN
complexes_NNS
in_IN
IL-2-secreting_JJ
cells_NNS
consisting_VBG
mainly_RB
of_IN
heterodimeric_JJ
p50\/p65_NN
complexes_NNS
._.

A_DT
weaker_JJR
chi_NN
B_NN
complex_NN
formation_NN
and_CC
faster-migrating_JJ
complexes_NNS
were_VBD
detected_VBN
in_IN
non-IL-2-secreting_JJ
cells_NNS
._.

These_DT
results_NNS
demonstrate_VBP
that_IN
the_DT
IL-2_NN
NF-chi_NN
B_NN
site_NN
is_VBZ
indispensable_JJ
for_IN
the_DT
activity_NN
of_IN
the_DT
IL-2_NN
promoter_NN
in_IN
EBV-transformed_JJ
B_NN
cells_NNS
,_,
whereas_IN
other_JJ
transcription_NN
factors_NNS
appear_VBP
to_TO
be_VB
less_RBR
important_JJ
for_IN
IL-2_NN
expression_NN
in_IN
these_DT
cells_NNS
._.

